
Brainsway Ltd. BWAY
$ 19.04
0.11%
Annual report 2024
added 12-27-2025
Brainsway Ltd. Operating Income 2011-2026 | BWAY
Operating profit (also called operating income or profit from core activities) is a financial metric that reflects a company's profit from its main operational activities before interest expenses and taxes are taken into account.
FormulaOperating profit = Revenue – Operating expensesFeatures of the metric
- Evaluates business efficiency
Shows how well the company controls its production and administrative costs. - Independent of financial structure
Excludes the impact of debt burden (interest) and taxes, allowing objective comparison of companies. - Main source for growth
High operating profit provides resources for investments, business expansion, and increased competitiveness.
If a company shows strong operating profit, it signals to investors that the core business is operating efficiently, even if net profit is temporarily reduced due to debt or tax burden.
Annual Operating Income Brainsway Ltd.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | -5 M | -4.83 M | -8.48 M | -5.11 M | -6.61 M | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -4.83 M | -8.48 M | -6.01 M |
Operating Income of other stocks in the Diagnostics research industry
| Issuer | Operating Income | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Akumin
AKU
|
-28.1 M | - | -17.87 % | $ 25.9 M | ||
|
Centogene N.V.
CNTG
|
-46 M | - | -6.23 % | $ 30.6 M | ||
|
Accelerate Diagnostics
AXDX
|
-14 M | - | -61.36 % | $ 2.46 M | ||
|
Biocept
BIOC
|
-32 M | - | -13.05 % | $ 7.29 M | ||
|
Burning Rock Biotech Limited
BNR
|
-797 M | $ 20.25 | -3.5 % | $ 217 M | ||
|
Co-Diagnostics
CODX
|
-42.7 M | $ 5.35 | 5.87 % | $ 157 M | ||
|
Castle Biosciences
CSTL
|
8.67 M | $ 38.31 | -1.52 % | $ 1.06 B | ||
|
Chembio Diagnostics
CEMI
|
-23.6 M | - | 0.22 % | $ 16.8 M | ||
|
Danaher Corporation
DHR
|
4.86 B | $ 230.53 | 0.7 % | $ 169 B | ||
|
DexCom
DXCM
|
598 M | $ 66.36 | -0.02 % | $ 25.6 B | ||
|
BioNano Genomics
BNGO
|
-104 M | $ 1.56 | 1.96 % | $ 1.98 M | ||
|
Enzo Biochem
ENZ
|
-12.4 M | - | -8.98 % | $ 14.8 K | ||
|
DermTech
DMTK
|
-104 M | - | -11.32 % | $ 2.94 M | ||
|
DarioHealth Corp.
DRIO
|
-56.2 M | $ 11.2 | -1.58 % | $ 318 M | ||
|
Exact Sciences Corporation
EXAS
|
-876 M | $ 101.8 | 0.24 % | $ 18.9 B | ||
|
IQVIA Holdings
IQV
|
2.2 B | $ 225.76 | 0.16 % | $ 40.9 B | ||
|
Fulgent Genetics
FLGT
|
-73.9 M | $ 25.77 | -1.9 % | $ 779 M | ||
|
Global Cord Blood Corporation
CO
|
609 M | - | - | $ 399 M | ||
|
Genetron Holdings Limited
GTH
|
-518 M | - | 0.12 % | $ 80.1 M | ||
|
Heska Corporation
HSKA
|
-20.3 M | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
-20.8 M | - | -20.0 % | $ 1.06 M | ||
|
CareDx, Inc
CDNA
|
-203 M | $ 19.08 | 1.27 % | $ 1.03 B | ||
|
Celcuity
CELC
|
-113 M | $ 99.7 | -0.05 % | $ 3.93 B | ||
|
Anixa Biosciences
ANIX
|
-13.8 M | $ 3.11 | -0.32 % | $ 99.2 K | ||
|
Myriad Genetics
MYGN
|
-124 M | $ 6.23 | 1.22 % | $ 564 M | ||
|
Guardant Health
GH
|
-444 M | $ 101.54 | -0.59 % | $ 12.5 B | ||
|
ENDRA Life Sciences
NDRA
|
-10.8 M | $ 4.21 | -7.06 % | $ 2.26 M | ||
|
NeoGenomics
NEO
|
-92.1 M | $ 11.7 | -0.51 % | $ 1.48 B | ||
|
National Research Corporation
NRC
|
40 M | $ 18.42 | -1.86 % | $ 452 M | ||
|
Aspira Women's Health
AWH
|
-32.8 M | - | -6.19 % | $ 10.5 M | ||
|
OPKO Health
OPK
|
-152 M | $ 1.32 | 4.37 % | $ 916 M | ||
|
Koninklijke Philips N.V.
PHG
|
553 M | $ 27.16 | 0.3 % | $ 20 B | ||
|
Precipio
PRPO
|
-7.62 M | $ 23.35 | 1.61 % | $ 30.3 M | ||
|
Personalis
PSNL
|
-68.3 M | $ 7.95 | -0.13 % | $ 471 M | ||
|
Motus GI Holdings
MOTS
|
-11.9 M | - | -34.28 % | $ 263 K | ||
|
Illumina
ILMN
|
-833 M | $ 132.66 | 1.14 % | $ 21.1 B | ||
|
Charles River Laboratories International
CRL
|
227 M | $ 200.04 | 0.28 % | $ 10.3 B | ||
|
Quest Diagnostics Incorporated
DGX
|
1.35 B | $ 172.92 | -0.35 % | $ 19.2 B | ||
|
Biodesix
BDSX
|
-34.5 M | $ 6.72 | -1.25 % | $ 871 M | ||
|
Laboratory Corporation of America Holdings
LH
|
1.09 B | $ 251.95 | 0.43 % | $ 21.1 B | ||
|
ICON Public Limited Company
ICLR
|
1.1 B | $ 188.4 | 3.39 % | $ 15.5 B | ||
|
IDEXX Laboratories
IDXX
|
1.13 B | $ 664.7 | -1.75 % | $ 54.8 B | ||
|
Lantheus Holdings
LNTH
|
457 M | $ 67.47 | 1.38 % | $ 4.67 B | ||
|
Agilent Technologies
A
|
1.35 B | $ 137.01 | 0.69 % | $ 41.7 B |